AIM IMMUNOTECH INC. Cash and Cash Equivalents, Fair Value Disclosure
AIM IMMUNOTECH INC. (AIM) had Cash and Cash Equivalents, Fair Value Disclosure of $6.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2025-08-14
- 2025-06-30: Cash and Cash Equivalents, Fair Value Disclosure $6.00K.
- 2025-03-31: Cash and Cash Equivalents, Fair Value Disclosure $15.00K.
- 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure $51.00K.
- 2023-12-31: Cash and Cash Equivalents, Fair Value Disclosure $4.80M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2025-06-30 | $6.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $51.00K 10-Q · filed 2025-08-14 |
| 2023-12-31 | $4.80M 10-K · filed 2025-03-27 |
| 2023-09-30 | $14.11M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $25.18M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |